Wugen, Inc

Kypha Inc is an immune insights company based in Saint Louis, MO, dedicated to unlocking the full diagnostic potential of the immune system. They offer integrated solutions that enable precise, real-time immune insights for earlier treatment decisions and better outcomes for patients with immune-related conditions. With their proprietary test system, deep expertise in rapid immunoassay and multiplex panel development, and connected data analytics, Kypha simplifies clinical protocols, minimizes resource and sample requirements, and delivers reliable and accessible insights in real-time. Their Precision Immune Monitoring (PIM) solutions provide comprehensive and clinically actionable results, helping biopharma and healthcare partners deliver the most effective therapies and highest quality of care to patients.Generated from the website

Canopy Biosciences, LLC, based in Saint Louis, MO, is a leading provider of cutting-edge spatial biology and multi-omic tools for biomedical researchers. Their innovative ChipCytometry technology and services, including single-cell sequencing and high plex biomarker imaging, enable scientists to drive scientific discovery faster. Empowering innovation, Canopy Biosciences, a Bruker company, offers end-to-end solutions for spatial and single-cell omics research. With capabilities such as NanoString gene expression analysis and 10X Genomics Chromium X Series sequencing, Canopy Biosciences facilitates precise quantification and unbiased profiling of genes at the single-cell level.Generated from the website

Immunophotonics, Inc. is a pioneering biotechnology company based in Saint Louis, MO, dedicated to unlocking the potential of the immune system through the development of a new class of therapeutics. Their proprietary glycan polymer technology stimulates antigen capture and uptake, triggering an immune response that enables the rejection of cancer and other diseases. With practical applications in interventional oncology, immunotherapy, and vaccine enhancement, Immunophotonics aims to elevate modern medicine and improve outcomes for patients worldwide. Through their innovative approach, Immunophotonics is transforming conventional surgical interventions into systemically active immunotherapies, upregulating T-cell activation, downregulating T-cell exhaustion, and driving stronger immune responses. Their powerful immunoadjuvant, IP-001, has the potential to enhance antigen-specific immunity against infectious diseases, including SARS-CoV-2, and increase the efficacy of vaccines. Committed to global human health, Immunophotonics is at the forefront of advancing medical treatments and improving patient outcomes.Generated from the website